Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02402855
Other study ID # BARDOU PREPS 2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 7, 2016
Est. completion date September 9, 2020

Study information

Verified date November 2020
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the impact of financial support on improving the management of prenatal care in pregnant women with low incomes. The judgment criterion is clinically pertinent: complications of pregnancy. This study also aims to evaluate attitudes to this approach through a qualitative survey. It is planned to include 4000 women distributed into two arms of 2000 each. One group will receive financial support (prepaid payment card credited for each consultation attended according to the scheduled follow-up as recommended by the Haute Autorité de Santé); the other group will not. The management of the pregnancy for both groups will not be modified.


Recruitment information / eligibility

Status Completed
Enrollment 3787
Est. completion date September 9, 2020
Est. primary completion date September 9, 2020
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Pregnant women - Age > 18 years - 1st consultation before the 26th week of amenorrhea - Recipient of free health care (Couverture Maladie Universelle, Couverture Maladie Universelle-Complémentaire) - Who have provided written informed consent to take part in the study Exclusion Criteria: - Persons without national health insurance cover - Persons unable to understand the information on the study, despite the help of a translator or a person of trust if necessary - Persons under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Delivery of a prepaid payment card
Delivery of a prepaid payment card credited according to consultations attended
Interview with a sociologist
For a sub-group of 40 womens
No intervention


Locations

Country Name City State
France CHRU de BESANCON Besancon
France CHRU de BREST Brest
France CHU de DIJON Dijon
France APHP maternité Kremlin Bicêtre Kremlin-bicetre
France CHRU de LILLE Lille
France APHM Hôpital Nord Marseille
France APHP Hopital Robert Debré Paris
France Chu Saint Etienne Saint Etienne
France Chu Tours Tours

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Maternal morbidity, mortality and rate of caesarean sections A composite outcome measure consisting of multiple measures: maternal mobidity, mortality and rate og caesarean sections Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Other Number of scheduled consultations attended in agreement with the minimal follow-up recommendations of the Haute Autorité de Santé Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Other Interview with a sociologist to evaluate perception of the intervention and evaluation of its perceived impact in follow-up of the pregnancy About 6 weeks after delivery
Other Differential cost-effectiveness ratio associated with the financial support compared with the absence of support and expressed in terms of cost per complication avoided Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Primary Occurence of complication(s) of pregnancy, wether maternal, fetal or neonatal Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Secondary Neonatal morbidity, mortality and rate of transfer of the newborn to a neonatal care unit. A composite outcome measure consisting of multiple measures: neonatal morbidity, mortality and rate of tranfer of the newborn to a neonatal care unit Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02528136 - The Clinical Carbetocin Myocardium Trial Phase 4